Cellectar Biosciences, Inc. Increase (Decrease) in Restricted Cash
Cellectar Biosciences, Inc. (CLRB) reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-05-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2015-05-20
- Cellectar Biosciences, Inc. increase (decrease) in restricted cash for the quarter ending 2014-12-31 was $0.00.
- Cellectar Biosciences, Inc. increase (decrease) in restricted cash for the quarter ending 2014-09-30 was $0.00.
- Cellectar Biosciences, Inc. increase (decrease) in restricted cash for the quarter ending 2014-06-30 was $0.00.
- Cellectar Biosciences, Inc. increase (decrease) in restricted cash for the quarter ending 2014-03-31 was $0.00.
- Cellectar Biosciences, Inc. increase (decrease) in restricted cash for fiscal 2014 was $0.00.
- Cellectar Biosciences, Inc. increase (decrease) in restricted cash for fiscal 2013 was -$2.00M, a 200.00% decline from fiscal 2012.
- Cellectar Biosciences, Inc. increase (decrease) in restricted cash for fiscal 2012 was $2.00M.
- Cellectar Biosciences, Inc. increase (decrease) in restricted cash for fiscal 2011 was -$500.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 104 month | Increase (Decrease) in Restricted Cash 107 month | Increase (Decrease) in Restricted Cash 110 month | Increase (Decrease) in Restricted Cash 113 month | Increase (Decrease) in Restricted Cash 116 month | Increase (Decrease) in Restricted Cash 119 month | Increase (Decrease) in Restricted Cash 122 month | Increase (Decrease) in Restricted Cash 125 month | Increase (Decrease) in Restricted Cash 128 month | Increase (Decrease) in Restricted Cash 131 month | Increase (Decrease) in Restricted Cash 134 month | Increase (Decrease) in Restricted Cash 137 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | $0.00 derived: sum of 2 quarters · filed 2015-05-20 | $0.00 derived: sum of 3 quarters · filed 2015-05-20 | $0.00 10-K · filed 2015-05-20 | ||||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-20 | $0.00 derived: sum of 2 quarters · filed 2015-05-20 | $0.00 10-Q · filed 2015-05-20 | $0.00 derived: sum of 4 quarters · filed 2015-05-20 | ||||||||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $0.00 10-Q · filed 2014-08-04 | $0.00 derived: sum of 3 quarters · filed 2015-05-20 | -$1.88M derived: sum of 4 quarters · filed 2015-05-20 | ||||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2015-05-20 | -$1.88M derived: sum of 3 quarters · filed 2015-05-20 | -$1.88M derived: sum of 4 quarters · filed 2015-05-20 | $55.00K 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | -$1.88M derived: sum of 2 quarters · filed 2015-05-20 | -$1.88M derived: sum of 3 quarters · filed 2015-05-20 | -$2.00M 10-K · filed 2015-05-20 | $55.00K 10-K · filed 2014-03-19 | |||||||||||
| 2013-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-20 | -$1.88M derived: sum of 2 quarters · filed 2015-05-20 | -$2.00M 10-Q · filed 2015-05-20 | $0.00 derived: sum of 4 quarters · filed 2015-05-20 | $55.00K 10-Q · filed 2013-11-13 | |||||||||||
| 2013-06-30 | -$28.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$121.77K 10-Q · filed 2014-08-04 | $1.88M derived: sum of 3 quarters · filed 2014-08-04 | $1.88M derived: sum of 4 quarters · filed 2014-08-04 | $1.93M 10-Q · filed 2013-08-12 | |||||||||||
| 2013-03-31 | -$121.74K 10-Q · filed 2014-05-14 | $1.88M derived: sum of 2 quarters · filed 2014-05-14 | $1.88M derived: sum of 3 quarters · filed 2014-05-14 | $1.88M derived: sum of 4 quarters · filed 2014-05-14 | $1.93M 10-Q · filed 2013-05-15 | |||||||||||
| 2012-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $2.00M derived: sum of 2 quarters · filed 2014-03-19 | $2.00M derived: sum of 3 quarters · filed 2014-03-19 | $2.00M 10-K · filed 2014-03-19 | $2.06M 10-K · filed 2013-03-28 | |||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-11-13 | $55.00K 10-Q · filed 2012-11-06 | |||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 | $0.00 derived: sum of 3 quarters · filed 2013-08-12 | $0.00 derived: sum of 4 quarters · filed 2013-08-12 | $55.00K 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | $0.00 derived: sum of 2 quarters · filed 2013-05-15 | $0.00 derived: sum of 3 quarters · filed 2013-05-15 | $55.00K 10-Q · filed 2012-05-04 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $0.00 derived: sum of 2 quarters · filed 2013-03-28 | -$500.00K 10-K · filed 2013-03-28 | $55.00K 10-K · filed 2012-03-09 | ||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$500.00K 10-Q · filed 2012-11-06 | $55.00K 10-Q · filed 2011-11-07 | |||||||||||||
| 2011-06-30 | -$500.00K 10-Q · filed 2012-08-09 | $55.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |